We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Approach to Thyroid Surgery Eliminates Neck Scar

By HospiMedica International staff writers
Posted on 31 Aug 2011
A new surgical option allows surgeons to conduct a robotic thyroidectomy using a gasless, transaxillary approach (TAA) for the management of thyroid carcinoma.

Researchers at Yonsei University College of Medicine (Seoul, South Korea) reported their experience of a consecutive series of 1,000 patients with thyroid cancer who underwent robotic thyroidectomy from October 2007 to November 2009 treated using a gasless TAA. More...
All patients were selected using predetermined inclusion criteria after considering surgical risk, and all procedures were completed using the da Vinci surgical system, a product of Intuitive Surgical (Sunnyvale, CA, USA). The patient's clinicopathologic characteristics, operation types, operation times, numbers of retrieved lymph nodes (LNs), postoperative hospital stays, complications, and short-term follow-up results were analyzed.

The results showed that 627 patients underwent less than total, and 373 patients underwent bilateral total thyroidectomy. Ipsilateral central compartment node dissection was conducted in all 1,000 cases, and additional lateral neck node dissection was conducted in 36 of the 1,000 patients. The mean operation time was 136 minutes, and mean postoperative hospital stay was 3 days. No serious postoperative complication occurred, except three cases of recurrent laryngeal nerve injury, and one case of Horner syndrome. Mean tumor size was 0.79 centimeter, and papillary thyroid microcarcinoma was present in 752 cases (75.5%). According to tumor nodes metastasis staging, 847 patients (84.7%) were of stage I, 144 patients (14.4%) were of stage III, and 9 patients (0.9%) were of stage IVA. The study was published in the August 2011 issue of Surgical Laporoscopy, Endoscopy & Percutaneous Techniques.

“Robotic thyroidectomy using a gasless TAA is a feasible, safe, and promising surgical alternative for selected patients with low-risk thyroid cancer,” concluded lead author Seong-Woong Kang, MD, and colleagues of the department of surgery. “We recommend that the inclusion criteria of this technique be gradually extended to advanced thyroid cancer given suitable operator experience and future developments in robotic systems and instrumentation.”

Thyroidectomy involves the surgical removal of all or part of the thyroid gland due to cancer or some other condition of the thyroid gland, such as hyperthyroidism. Other indications for surgery include cosmetic reasons or symptomatic obstruction causing difficulties in swallowing or breathing. One of the complications of thyroidectomy is voice change, and patients are strongly advised to request protection of the voice by using electronic nerve monitoring. Most thyroidectomies are now performed by minimally invasive surgery using a cut in the neck of no more than 2.5 centimeters.

Related Links:

Yonsei University College of Medicine
Intuitive Surgical



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.